Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02524379 · ClinicalTrials.gov registry record · Phase 1
Spinal Cord Injury Neuroprotection With Glyburide
A Phase 1 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02524379 is a Phase 1 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 3 participants.
The verdict
NCT02524379, a Phase 1 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of using oral Glyburide in patients with acute traumatic cervical spinal cord injuries (SCI).
Interventions
- DRUG Glyburide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2021-02-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02524379
The ClinicalTrials.gov registry entry for NCT02524379 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glyburide is the first listed.
NCT02524379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02524379 about?
NCT02524379 is a clinical study titled "Spinal Cord Injury Neuroprotection With Glyburide". The purpose of this study is to determine the safety of using oral Glyburide in patients with acute traumatic cervical spinal cord injuries (SCI).
What is the current status of trial NCT02524379?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2017-02-14. Estimated completion is 2021-02-08.
What interventions are being tested in trial NCT02524379?
The interventions under investigation include: Glyburide (DRUG).
Who is sponsoring clinical trial NCT02524379?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.